A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor
Clinical trial NCT01994213 · TERMINATED
Trial details
- NCT number
- NCT01994213
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-11-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.